How The IRA Could Delay Pharmaceutical Launches, Reduce Indications, And Chill Evidence Generation

Clinical development programs for new drugs include an array of research conducted both before and after a drug’s initial approval by the Food and Drug Administration (FDA). Post-approval clinical trials may be conducted in new patient populations to support additional indications and to demonstrate long-term safety and efficacy, including impacts on overall survival or major health events.

Read full story